Accéder au contenu
Merck

TRIM11, a new target of p53, facilitates the migration and invasion of nasopharyngeal carcinoma cells.

Molecular biology reports (2022-11-15)
Ziyi Zhao, Jinkuang Deng, Ming Lu, Jun Yang, Linlin Chen, DianYuan Li, Yi Sang
RÉSUMÉ

Although tripartite motif-containing protein 11 (TRIM11) is known to be associated with a variety of cancers, its role in nasopharyngeal carcinoma (NPC) is unclear. To investigate the role of TRIM11 in NPC, TRIM11 was stably overexpressed in 6-10B and CNE2 cells with lentiviral vectors and knocked down in S18 and 5-8F cells using the CRISPR/Cas9 system. Transwell assays and wound-healing assays revealed that TRIM11 facilitated the migration and invasion of NPC cells. Mechanistically, we found that p53 inhibits TRIM11 expression by binding to its promoter. TRIM11 may serve as a potential diagnostic marker for NPC and has a certain therapeutic value.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Anti-TRIM11 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution